These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The hepatitis C virus life cycle as a target for new antiviral therapies. Pawlotsky JM; Chevaliez S; McHutchison JG Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890 [TBL] [Abstract][Full Text] [Related]
6. A primer on the molecular virology of hepatitis C. Moradpour D; Blum HE Liver Int; 2004 Dec; 24(6):519-25. PubMed ID: 15566499 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus genetic variability in patients undergoing antiviral therapy. Cristina J; del Pilar Moreno M; Moratorio G Virus Res; 2007 Aug; 127(2):185-94. PubMed ID: 17449128 [TBL] [Abstract][Full Text] [Related]
8. Structural biology of hepatitis C virus. Penin F; Dubuisson J; Rey FA; Moradpour D; Pawlotsky JM Hepatology; 2004 Jan; 39(1):5-19. PubMed ID: 14752815 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus: prospects for future therapies. Wilkinson T Curr Opin Investig Drugs; 2001 Nov; 2(11):1516-22. PubMed ID: 11763151 [TBL] [Abstract][Full Text] [Related]
10. Future options for the management of hepatitis C. Davis GL; Nelson DR; Reyes GR Semin Liver Dis; 1999; 19 Suppl 1():103-12. PubMed ID: 10349698 [TBL] [Abstract][Full Text] [Related]
11. The way forward in HCV treatment--finding the right path. Manns MP; Foster GR; Rockstroh JK; Zeuzem S; Zoulim F; Houghton M Nat Rev Drug Discov; 2007 Dec; 6(12):991-1000. PubMed ID: 18049473 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis C viral life cycle. Suzuki T; Ishii K; Aizaki H; Wakita T Adv Drug Deliv Rev; 2007 Oct; 59(12):1200-12. PubMed ID: 17825945 [TBL] [Abstract][Full Text] [Related]
13. Chemical genetics approach to hepatitis C virus replication: cyclophilin as a target for anti-hepatitis C virus strategy. Watashi K; Shimotohno K Rev Med Virol; 2007; 17(4):245-52. PubMed ID: 17299803 [TBL] [Abstract][Full Text] [Related]
14. HCV-hepatocellular carcinoma: new findings and hope for effective treatment. Dash S; Haque S; Joshi V; Prabhu R; Hazari S; Fermin C; Garry R Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514 [TBL] [Abstract][Full Text] [Related]
15. Evaluation systems for anti-HCV drugs. Moriishi K; Matsuura Y Adv Drug Deliv Rev; 2007 Oct; 59(12):1213-21. PubMed ID: 17720275 [TBL] [Abstract][Full Text] [Related]
16. HCV research and anti-HCV drug discovery: toward the next generation. Wakita T Adv Drug Deliv Rev; 2007 Oct; 59(12):1196-9. PubMed ID: 17905463 [TBL] [Abstract][Full Text] [Related]
17. Treatment and vaccination for hepatitis C: present and future. Jawaid A; Khuwaja AK J Ayub Med Coll Abbottabad; 2008; 20(1):129-33. PubMed ID: 19024206 [TBL] [Abstract][Full Text] [Related]
18. The management of hepatitis C. Pan JJ; Firpi RJ Minerva Gastroenterol Dietol; 2009 Mar; 55(1):23-35. PubMed ID: 19212305 [TBL] [Abstract][Full Text] [Related]
19. Application of the trak-C HCV core assay for monitoring antiviral activity in HCV replication systems. Cagnon L; Wagaman P; Bartenschlager R; Pietschmann T; Gao T; Kneteman NM; Tyrrell DL; Bahl C; Niven P; Lee S; Simmen KA J Virol Methods; 2004 Jun; 118(1):23-31. PubMed ID: 15158065 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus p7: molecular function and importance in hepatitis C virus life cycle and potential antiviral target. Khaliq S; Jahan S; Hassan S Liver Int; 2011 May; 31(5):606-17. PubMed ID: 21457434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]